Literature DB >> 11182227

Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus.

A C Goldberg1, P L Bittencourt, B Mougin, E L Cançado, G Porta, F Carrilho, J Kalil.   

Abstract

Susceptibility to autoimmune hepatitis type I (AIH-1) has been associated with HLA-DR3, DR52, and DR4 antigens in Caucasian and Oriental patients. However, in Brazil, disease susceptibility is primarily linked to DR13 and DR52. In this highly admixed population, we find different DR13-associated haplotypes, presenting a unique opportunity to discriminate relevant genes within a tightly linked genomic region. To identify the primary susceptibility locus, we sequenced DR13 alleles of 39 patients with AIH-1 and 22 controls. Patients were almost exclusively DRB1*1301, but half of controls typed DRB1*1302. HLA-DQ haplotypes were varied. Oligotyping of DRB3 locus of all patients and also within the HLA-DR13 positive group showed an allele distribution comparable to controls, confirming that the stronger association lies in the DRB1 locus. On the other hand, if DRB1*1301 is the major susceptibility factor in our sample, the only amino acid different from DRB1*1302 in position 86, corresponding to pocket 1 in the peptide-presenting groove, may be important. We propose that peptide presentation leading to pathogenesis of AIH-1 may be quite stringent, but will also be affected by other strong genetic or environmental susceptibility factors, which would explain the various HLA molecules associated to the disease in the different populations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11182227     DOI: 10.1016/s0198-8859(00)00234-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  16 in total

Review 1.  Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2017-07-14       Impact factor: 3.199

2.  Relationship between autoimmune hepatitis and HLA-DR4 and DRbeta allelic sequences in the third hypervariable region in Chinese.

Authors:  X Ma; D K Qiu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

Review 3.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

4.  Genetic distinctions between autoimmune hepatitis in Italy and North America.

Authors:  Paolo Muratori; Albert-J Czaja; Luigi Muratori; Georgios Pappas; Silvana Maccariello; Fabio Cassani; Alessandro Granito; Rodolfo Ferrari; Vilma Mantovani; Marco Lenzi; Francesco-B Bianchi
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

5.  Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.

Authors:  Agustin Castiella; Eva Zapata; M Isabel Lucena; Raúl J Andrade
Journal:  World J Hepatol       Date:  2014-04-27

Review 6.  Autoimmune hepatitis--approach to diagnosis.

Authors:  Albert J Czaja
Journal:  MedGenMed       Date:  2006-05-23

Review 7.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

Review 8.  Mechanisms of tissue injury in autoimmune liver diseases.

Authors:  Evaggelia Liaskou; Gideon M Hirschfield; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2014-08-01       Impact factor: 9.623

9.  HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients.

Authors:  Albert J Czaja; Herschel A Carpenter; S Breanndan Moore
Journal:  Dig Dis Sci       Date:  2007-05-18       Impact factor: 3.199

Review 10.  Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.